// App-Quantinova.ai

: Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Cancer Patients Undergoing Central Line Placement: A Phase 2 Clinical Trial

Researchers

Presenter

  • Michael A Pfeffer

Principal Investigators

  • Helen Vu

  • Tia CL Kohs

  • Jenny Wang

  • Christina U Lorentz

  • Erik I Tucker

  • Sven R Olson

  • Thomas G Deloughery

  • Monica T Hinds

  • Owen JT McCarty

  • Joseph J Shatzel

Medical Centers

  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR

  • Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Brain metastasis

  • Thrombocytopenia

  • Acute Leukemia

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Non Interventional

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved